Efficacy and risks of fondaparinux 7.5 mg for deep vein thrombosis after total knee arthroplasty

OBJECTIVES: High-dose fondaparinux therapy at 7.5 mg/day (FPX 7.5 mg) for deep vein thrombosis (DVT) may increase the risk of hemorrhage. We investigated the efficacy and safety of FPX 7.5 mg to treat DVT after total knee arthroplasty. METHODS: This study included 101 patients (91 with osteoarthriti...

Descripción completa

Detalles Bibliográficos
Autores principales: Nojiri, Sho, Hayakawa, Kazue, Date, Hideki, Yamada, Harumoto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Fujita Medical Society 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8766234/
https://www.ncbi.nlm.nih.gov/pubmed/35111494
http://dx.doi.org/10.20407/fmj.2017-020

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8766234/
https://www.ncbi.nlm.nih.gov/pubmed/35111494
http://dx.doi.org/10.20407/fmj.2017-020

Ejemplares similares